🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Left Lateral Position vs Supine Position to Reduce Active Labor Duration

RecruitingNAAges 18 Years - 45 YearsFemaleUniversidad Nacional Autonoma de Honduras
NCT07411352 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized clinical trial aims to compare the effect of the left lateral decubitus position versus the supine position on the duration of the active phase of labor in nulliparous women. A total of 188 participants will be randomly assigned to one of two groups. The intervention group will be placed in the left lateral decubitus position, while the control group will remain in the supine position. Both positions will be maintained for 30-minute intervals with 5-minute rest periods, continuing until delivery. The primary outcome is the duration of the active phase of labor. Secondary outcomes include rates of cesarean section, use of oxytocin and analgesics, and maternal and neonatal complications.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Signed and dated informed consent form. * Nulliparous woman. * Singleton pregnancy at ≥37 weeks of gestation. * Intact amniotic membranes. * Cephalic presentation. * In the active phase of labor (cervical dilation ≥6 cm). * Age ≥18 years. * No contraindication for vaginal delivery. * Possession of a mobile phone (for potential follow-up contact). Exclusion Criteria: * Previous uterine surgery. * Maternal condition preventing vaginal delivery. * Fetal anomaly. * Premature rupture of membranes. * Multiple pregnancy. * Fetal demise. * Uterine myomas. * Maternal comorbidities (e.g., chronic hypertension, diabetes mellitus type -1/2/gestational, hypothyroidism). * Anemia. * Age \<18 years. * Preterm gestation (\<37 weeks).
💊

What it tests

  • Left Lateral Decubitus Group
  • Supine Position Group
📍

Where

1 site
Hospital Escuela
Tegucigalpa, Honduras
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy